Rhumbline Advisers Nuvasive Inc Transaction History

Rhumbline Advisers

$103 Billion
Q1 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$36.71 - $44.15 $182,301 - $219,248	4,966 Added 3.05%	167,882 $6.98 Million
Q1 2023 May 11, 2023	BUY	$36.81 - $48.12 $238,823 - $312,202	6,488 Added 4.15%	162,916 $6.73 Million
Q4 2022 Feb 14, 2023	SELL	$35.68 - $44.71 $426,161 - $534,016	-11,944 Reduced 7.09%	156,428 $6.45 Million
Q3 2022 Nov 10, 2022	BUY	$42.51 - $54.02 $259,906 - $330,278	6,114 Added 3.77%	168,372 $7.38 Million
Q2 2022 Aug 11, 2022	BUY	$46.84 - $59.75 $649,483 - $828,493	13,866 Added 9.34%	162,258 $7.98 Million

Q1 2022 May 12, 2022	BUY	$48.09 - $57.79 $187,791 - $225,669	3,905 Added 2.7%	148,392 $8.41 Million
Q4 2021 Feb 10, 2022	SELL	$47.19 - $62.68 $46,340 - $61,551	-982 Reduced 0.68%	144,487 $7.58 Million
Q3 2021 Nov 12, 2021	SELL	$56.91 - $67.81 $19,349 - $23,055	-340 Reduced 0.23%	145,469 $8.71 Million
Q2 2021 Aug 05, 2021	BUY	$64.02 - $71.72 $14,020 - $15,706	219 Added 0.15%	145,809 $9.88 Million
Q1 2021 May 06, 2021	SELL	$53.26 - $68.08 $523,758 - $669,498	-9,834 Reduced 6.33%	145,590 $9.55 Million
Q4 2020 Feb 10, 2021	BUY	$43.41 - $56.51 $356,613 - $464,229	8,215 Added 5.58%	155,424 $8.76 Million
Q3 2020 Nov 12, 2020	SELL	$47.43 - $60.75 $1.17 Million - $1.49 Million	-24,591 Reduced 14.31%	147,209 $7.15 Million
Q2 2020 Aug 13, 2020	BUY	$43.51 - $66.59 $487,312 - $745,808	11,200 Added 6.97%	171,800 $9.56 Million
Q1 2020 May 06, 2020	SELL	$32.82 - $81.13 $93,340 - $230,733	-2,844 Reduced 1.74%	160,600 $8.14 Million
Q4 2019 Feb 05, 2020	SELL	$60.96 - $77.7 $202,509 - $258,119	-3,322 Reduced 1.99%	163,444 $12.6 Million
Q3 2019 Oct 23, 2019	SELL	$55.78 - $68.08 $68,218 - $83,261	-1,223 Reduced 0.73%	166,766 $10.6 Million
Q2 2019 Aug 14, 2019	BUY	$53.69 - $65.47 $114,144 - $139,189	2,126 Added 1.28%	167,989 $9.83 Million
Q1 2019 May 01, 2019	BUY	$44.53 - $58.9 $102,552 - $135,646	2,303 Added 1.41%	165,863 $9.42 Million
Q4 2018 Jan 31, 2019	BUY	$47.64 - $71.26 $3.11 Million - $4.65 Million	65,200 Added 66.29%	163,560 $8.11 Million
Q3 2018 Nov 07, 2018	SELL	$52.03 - $71.41 $235,539 - $323,273	-4,527 Reduced 4.4%	98,360 $6.98 Million
Q2 2018 Aug 06, 2018	BUY	$48.15 - $56.68 $85,947 - $101,173	1,785 Added 1.77%	102,887 $5.36 Million
Q1 2018 May 02, 2018	SELL	$46.03 - $61.28 $301,358 - $401,200	-6,547 Reduced 6.08%	101,102 $5.28 Million
Q4 2017 Feb 09, 2018	SELL	$50.58 - $60.79 $765,578 - $920,117	-15,136 Reduced 12.33%	107,649 $6.3 Million
Q3 2017 Nov 06, 2017	BUY	$53.54 - $68.0 $6.57 Million - $8.35 Million	122,785	122,785 $6.81 Million

Others Institutions Holding NUVA

# of Institutions

Shares Held

116K

Call Options Held

Put Options Held

View Full List

About NUVASIVE INC

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

More about NUVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account